Nonhematopoietic Cells Control the Outcome of Infection with Listeria Monocytogenes in a Nucleotide Oligomerization Domain 1-dependent Manner

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2009 Apr 29

PMID 19398545

Citations 19

Authors

Ahmed Mosa

Christian Trumstedt

Emma Eriksson

Oliver Soehnlein

Frank Heuts

Katrin Janik

Andreas Klos

Oliver Dittrich-Breiholz

Michael Kracht

Asa Hidmark

Hans Wigzell

Martin E Rottenberg

Affiliations

Soon will be listed here.

Abstract

We analyzed the defensive role of the cytosolic innate recognition receptor nucleotide oligomerization domain 1 (NOD1) during infection with Listeria monocytogenes. Mice lacking NOD1 showed increased susceptibility to systemic intraperitoneal and intravenous infection with high or low doses of L. monocytogenes, as measured by the bacterial load and survival. NOD1 also controlled dissemination of L. monocytogenes into the brain. The increased susceptibility to reinfection of NOD1(-/-) mice was not associated with impaired triggering of listeria-specific T cells, and similar levels of costimulatory molecules or activation of dendritic cells was observed. Higher numbers of F480(+) Gr1(+) inflammatory monocytes and lower numbers of F480(-) Gr1(+) neutrophils were recruited into the peritoneum of infected WT mice than into the peritoneum of infected NOD1(-/-) mice. We determined that nonhematopoietic cells accounted for NOD1-mediated resistance to L. monocytogenes in bone marrow radiation chimeras. The levels of NOD1 mRNA in fibroblasts and bone marrow-derived macrophages (BMM) were upregulated after infection with L. monocytogenes or stimulation with different Toll-like receptor ligands. NOD1(-/-) BMM, astrocytes, and fibroblasts all showed enhanced intracellular growth of L monocytogenes compared to WT controls. Gamma interferon-mediated nitric oxide production and inhibition of L. monocytogenes growth were hampered in NOD1(-/-) BMM. Thus, NOD1 confers nonhematopoietic cell-mediated resistance to infection with L. monocytogenes and controls intracellular bacterial growth in different cell populations in vitro.

Citing Articles

Synthesis and validation of click-modified NOD1/2 agonists.

Bharadwaj R, Anonick M, Jaiswal S, Mashayekh S, Brown A, Wodzanowski K Innate Immun. 2023; 29(8):186-200.

PMID: 37828863 PMC: 10621468. DOI: 10.1177/17534259231207198.

The role of NOD-like receptors in innate immunity.

Almeida-da-Silva C, Savio L, Coutinho-Silva R, Ojcius D Front Immunol. 2023; 14:1122586.

PMID: 37006312 PMC: 10050748. DOI: 10.3389/fimmu.2023.1122586.

IFN-γ production by brain-resident cells activates cerebral mRNA expression of a wide spectrum of molecules critical for both innate and T cell-mediated protective immunity to control reactivation of chronic infection with .

Suzuki Y, Lutshumba J, Chen K, Abdelaziz M, Sa Q, Ochiai E Front Cell Infect Microbiol. 2023; 13:1110508.

PMID: 36875520 PMC: 9975934. DOI: 10.3389/fcimb.2023.1110508.

Exosomes derived from bone marrow mesenchymal stem cells protect the injured spinal cord by inhibiting pericyte pyroptosis.

Zhou Y, Wen L, Li Y, Wu K, Duan R, Yao Y Neural Regen Res. 2021; 17(1):194-202.

PMID: 34100456 PMC: 8451579. DOI: 10.4103/1673-5374.314323.

NOD1 and NOD2 in inflammatory and infectious diseases.

Trindade B, Chen G Immunol Rev. 2020; 297(1):139-161.

PMID: 32677123 PMC: 8928416. DOI: 10.1111/imr.12902.

References

Kim Y, Park J, Shaw M, Franchi L, Inohara N, Nunez G . The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity. 2008; 28(2):246-57. DOI: 10.1016/j.immuni.2007.12.012. View

Uehara A, Yang S, Fujimoto Y, Fukase K, Kusumoto S, Shibata K . Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in.... Cell Microbiol. 2004; 7(1):53-61. DOI: 10.1111/j.1462-5822.2004.00433.x. View

Montoya M, Schiavoni G, Mattei F, Gresser I, Belardelli F, Borrow P . Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood. 2002; 99(9):3263-71. DOI: 10.1182/blood.v99.9.3263. View

Girardin S, Boneca I, Carneiro L, Antignac A, Jehanno M, Viala J . Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science. 2003; 300(5625):1584-7. DOI: 10.1126/science.1084677. View

Netea M, Ferwerda G, de Jong D, Jansen T, Jacobs L, Kramer M . Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol. 2005; 174(10):6518-23. DOI: 10.4049/jimmunol.174.10.6518. View

Herskovits A, Auerbuch V, Portnoy D . Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system. PLoS Pathog. 2007; 3(3):e51. PMC: 1839167. DOI: 10.1371/journal.ppat.0030051. View

Kim J, Lee S, Kagnoff M . Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by toll-like receptors. Infect Immun. 2004; 72(3):1487-95. PMC: 356064. DOI: 10.1128/IAI.72.3.1487-1495.2004. View

Inohara N, Koseki T, del Peso L, Hu Y, Yee C, Chen S . Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J Biol Chem. 1999; 274(21):14560-7. DOI: 10.1074/jbc.274.21.14560. View

Viala J, Chaput C, Boneca I, Cardona A, Girardin S, Moran A . Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol. 2004; 5(11):1166-74. DOI: 10.1038/ni1131. View

10.

Portnoy D, Schreiber R, Connelly P, Tilney L . Gamma interferon limits access of Listeria monocytogenes to the macrophage cytoplasm. J Exp Med. 1989; 170(6):2141-6. PMC: 2189551. DOI: 10.1084/jem.170.6.2141. View

11.

Kotani S, Watanabe Y, Shimono T, Narita T, Kato K . Immunoadjuvant activities of cell walls, their water-soluble fractions and peptidoglycan subunits, prepared from various gram-positive bacteria, and of synthetic n-acetylmuramyl peptides. Z Immunitatsforsch Exp Klin Immunol. 1975; 149(2-4):302-19. View

12.

Travassos L, Carneiro L, Girardin S, Boneca I, Lemos R, Bozza M . Nod1 participates in the innate immune response to Pseudomonas aeruginosa. J Biol Chem. 2005; 280(44):36714-8. DOI: 10.1074/jbc.M501649200. View

13.

Girardin S, Travassos L, Herve M, Blanot D, Boneca I, Philpott D . Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem. 2003; 278(43):41702-8. DOI: 10.1074/jbc.M307198200. View

14.

Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L . An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol. 2003; 4(7):702-7. DOI: 10.1038/ni945. View

15.

Serbina N, Pamer E . Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol. 2006; 7(3):311-7. DOI: 10.1038/ni1309. View

16.

ORiordan M, Yi C, Gonzales R, Lee K, Portnoy D . Innate recognition of bacteria by a macrophage cytosolic surveillance pathway. Proc Natl Acad Sci U S A. 2002; 99(21):13861-6. PMC: 129788. DOI: 10.1073/pnas.202476699. View

17.

Kobayashi K, Inohara N, Hernandez L, Galan J, Nunez G, Janeway C . RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature. 2002; 416(6877):194-9. DOI: 10.1038/416194a. View

18.

Stetson D, Medzhitov R . Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity. 2006; 24(1):93-103. DOI: 10.1016/j.immuni.2005.12.003. View

19.

Werts C, Le Bourhis L, Liu J, Magalhaes J, Carneiro L, Fritz J . Nod1 and Nod2 induce CCL5/RANTES through the NF-kappaB pathway. Eur J Immunol. 2007; 37(9):2499-508. DOI: 10.1002/eji.200737069. View

20.

Jin Y, Dons L, Kristensson K, Rottenberg M . Neural route of cerebral Listeria monocytogenes murine infection: role of immune response mechanisms in controlling bacterial neuroinvasion. Infect Immun. 2001; 69(2):1093-100. PMC: 97990. DOI: 10.1128/IAI.69.2.1093-1100.2001. View